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Background:  Hepatitis C virus (HCV) is a silent epidemic affecting a vulnerable 
patient population in our society.  Among those considered high risk for having HCV 
are those individuals born between 1945 and 1965, termed the baby boomer 
population.  Baby boomers are five times more likely to have and suffer mortality 
from HCV than any other patient population (CDC, 2018).  HCV may not present with 
signs or symptoms until 20 to 30 years post contraction of the virus (CDC, 2018).  In 
2012, the Centers for Disease Control and Prevention (CDC) updated its 
recommendations for Hepatitis C screenings to include the baby boomer population 
(Guo & Sims, 2017).  Despite the CDC recommendation, it is estimated that an 
average of 13% of baby boomers have been screened (Kasting et al., 2018).  The 
purpose of this quality improvement project was to increase HCV screenings in the 
baby boomer population in outpatient family practice by providing clinical staff 
awareness of the need to screen.  
Methods:  A retrospective chart review was conducted by utilizing the Epic electronic 
health record (EHR) system, to determine the number of current patients born between 
1945 and 1965 who had not been diagnosed or previously screened for HCV.  Data was 
entered in “REDCap,” a web application that supports data collection (REDCap, 2019).  
Patients were linked by a unique patient identification number.  Patient data collected 
included; age, sex, year of birth, race, date of screening, zip code, HCV test result, 
insurance, visit type (lab versus provider), screened/not screened.  If not screened, the 






results from the HCV education evaluation were uploaded in REDCap.  The Plan, Do, 
Study, Act (PDSA) Cycle served as the framework for this 12-week project.  The 
theoretical frameworks guiding this project were The Institute for Healthcare 
Improvement (IHI) Triple Aim and The Health Belief Model (HBM).    
Intervention:  HCV education was provided to clinical staff to detail the importance of 
and evaluate their basic knowledge of HCV facts and screening in the 1945 to 1965 
patient population.  Patients who had not been previously screened were identified on the 
provider and lab schedules. HCV education was provided to patients at the clinical visit.  
If the patient consented, an HCV antibody screening test was ordered.    
Results:  HCV screenings increased 82% for the project period.  HCV screening rates in 
the baby boomer population for the practice increased from 31% to 42% by project end, 
suggesting that the clinical staff’s educational intervention increased the awareness of 
HCV, thus increasing screening rates for the practice.  Screening rates decreased monthly 
following the educational intervention, suggesting that there may have been decreased 
motivation by staff to screen and additionally indicating the need for re-education at 











Hepatitis C is a blood borne viral infection of the liver that occurs as an acute or 
chronic infection.  Approximately 15% to 25% of those who contract acute Hepatitis C 
will spontaneously clear the infection (Centers for Disease Control and Prevention 
[CDC], 2018).  The remaining 75% to 85% with acute infection progress to chronic 
infection (CDC, 2018).  Without treatment, Hepatitis C can cause damaging effects to the 
liver.  According to the CDC (2018), approximately 10% to 20% of those who develop a 
chronic infection, will develop cirrhosis over 20 to 30 years, and 1% to 5% will suffer 
mortality from liver decompensation or liver cancer.  Approximately, 2.7 to 3.9 million 
people have chronic Hepatitis C in the United States (CDC, 2018).  The delay between 
acute and chronic infection can be up to 20 to 30 years (CDC, 2018).  In 2007, mortality 
from HCV surpassed that of HIV in the United States (Galbraith et al., 2014).  In 2017, 
The CDC reported that more Americans were killed by Hepatitis C than any other 
infectious disease (CDC, 2017).  The incidence and prevalence, along with mortality rate, 
mean that HCV is an important challenge for health professionals to address with all 
Americans.  Some persons are at greater risk and require specific focus.     
Epidemiologic data obtained from The National Health and Nutrition 
Examination Survey from 1999 – 2008 found that baby boomers (those born between 
1945 and 1965) accounted for nearly 80% of all HCV cases in the United States (Guo & 
Sims, 2017).  The National Health and Interview Survey from 2013 – 2015 found that 
HCV screenings in the baby boomer birth-cohort were only at 13% (Kasting et al., 2018).  
The baby boomer birth-cohort is five times more likely to have HCV than the general 





between 1945 and 1965, in other words for every 100 patients diagnosed with HCV, 75 
are baby boomers (CDC, 2016).  HCV was first known as non-A, non-B hepatitis in the 
1970s as a cause for posttransfusion hepatitis (Gupta, Bajpai, & Choudhary, 2014).  It 
was not until 1989 that HCV was discovered (Gupta et al., 2014).  Baby boomers were 
thought to be exposed to HCV by blood transfusions that occurred prior to 1992 before 
safe screening practices were initiated.  Prior to 1992, blood transfusions carried an HCV 
risk of 15 to 20% per each unit transfused (Gupta et al., 2014).  The baby boomer 
population is now reaching the most prevalent stages of chronic HCV sequelae (Virginia 
Department of Health [VDH], 2017).  Most cases of chronic HCV were found to be in 
those aged 50 and older (CDC, 2018).  In 2015, nearly 20,000 Americans, most of whom 
were aged 55 and older, died from HCV related causes (CDC, 2017).  In 2014, this birth-
cohort suffered 19,659 HCV-related deaths after presenting with advanced disease from 
decades of being infected (Shaffer & Ahuja, 2017).  Nationwide the baby boomer 
generation is at risk for HCV.    
In addition to the national HCV needs, Hepatitis C virus infection is a growing 
epidemic, specifically in Virginia.  In 2012, there were 6,600 reported cases of acute and 
chronic Hepatitis C reported to the Virginia Department of Health (VDH, 2017).  In 
2015, the VDH received 8,043 newly reported cases of acute and chronic Hepatitis C 
(VDH, 2017).  In 2017, HCV was the most prevalent disease reported in over half of the 
state of Virginia (VDH, 2017).  In 2017, this number increased to 11,555 cases of acute 
and chronic Hepatitis C reported to the Health Department in Virginia, but the actual  
number is thought to be even higher, as many cases go unreported (VDH, 2017).  In 





Virginia Electronic Disease Surveillance System (VEDSS), there were just over 40 cases 
of acute HCV and just over 6,000 cases of chronic HCV in 2013 (VDH, 2016).  These 
numbers doubled by 2017 with nearly 80 acute HCV cases and close to 14,000 chronic 
HCV cases (VDH, 2018).  
Review of Literature 
A systematic literature review was conducted in September of 2017 and updated 
in October 2018 to identify studies that performed Hepatitis C testing for the baby 
boomer birth-cohort.  Searches were conducted for implementation of screening 
processes, both inside and outside of the primary care office that may have proved 
successful or provide prospects for future testing.  Comprehensive literature searches 
were conducted utilizing Google Scholar, Cumulative Index to Nursing and Allied Health 
(CINAHL), CINAHL PLUS, Medline, Medline Plus, Medscape, UpToDate, and 
PubMed.  Additional searches included the Centers for Disease Control and Prevention, 
Virginia Department of Health, and The US Preventive Services Task Force website.  
Key words used to search included; Hepatitis C, Hepatitis C Screenings, combined with 
“and” to the terms birth cohort or implementation or implementation strategies or 
barriers or provider barriers.  Article abstracts were reviewed for inclusion.  If related to 
outpatient implementation or review of testing strategies in this birth-cohort, they were 
included.  Notable articles were excluded if they focused on hospital screenings, personal  
characteristics of those with Hepatitis C, or those already diagnosed with Hepatitis C and 
receiving treatment.  A total of 30 articles were reviewed.      
In 2010, the Institute of Medicine (IOM) recognized Hepatitis C as a growing 





screening guidelines from risk-based to birth-cohort screening (Guo & Sims, 2017).  In 
2013, the U.S. Preventive Services Task Force (USPSTF) supported birth-cohort testing 
and upgraded HCV from a grade D to grade B recommendation (USPSTF, 2016).  The 
USPSTF grade B recommendation states, “there is high certainty that the net benefit is 
moderate or there is moderate certainty that the net benefit is moderate to substantial” 
(USPSTF, 2018).  A grade B rating is suggested for practice.  The birth-cohort screening 
recommendation was implemented to increase screenings and identify undiagnosed HCV 
in this high prevalence patient population (Guo & Sims, 2017).  Despite these 
recommendations, screenings of this birth-cohort are only at 13% (Kasting et al., 2018).   
It is estimated that a one-time screening in this birth-cohort will identify 1.1 
million infections (Guo & Sims, 2017).  Identification and treatment of these individuals 
can preclude more than 120,000 HCV-related deaths (CDC, 2018).  Guo & Sims (2017) 
estimated the HCV epidemic will peak in the United States between 2030 and 2035.  It is 
estimated that between 2030 and 2035, there could be 35,000 HCV related deaths, 25,000 
cases of decompensated cirrhosis, and 15,000 cases of hepatocellular carcinoma caused 
by HCV annually (Guo & Sims, 2017).   
There is a strong recommendation by USPSTF to screen for HCV in primary care 
(USPSTF, 2016).  Birth-cohort screening in primary care is thought to be more efficient  
due to continuum of care by primary care providers and linkage to treatment (Konerman 
et al., 2017).  Conversely, there is limited data regarding HCV screenings in primary 
care.  Konerman et al. (2017) implemented a best practice alert (BPA) in the EHR to 
increase HCV screenings in the baby boomer population in primary care.  Screening rates 





referred for specialty care (Konerman et al., 2017).  Litwin et al. (2011) used clinical 
reminder interventions to increase HCV testing rates resulting in birth-cohort testing 
increase from 6.0% at baseline to 9.9% during the testing period in primary care (Litwin 
et al., 2011).  Madhani, Aamar, and Chia (2017) used education dissemination to increase 
birth-cohort screenings in their resident continuity clinic.  Birth-cohort screenings 
increased from 8.5% at baseline to 34% post intervention (Madhani et al., 2017).  Al-hihi, 
Shankweiler, Stricklen, Gibson, and Dunn (2017) implemented an electronic medical 
record alert for birth-cohort testing in primary care.  In this example, birth-cohort 
screenings increased from 30% at baseline to 55% post-intervention (Al-hihi et al., 2017).   
 Instituting a BPA combined with ongoing HCV education for project adherence 
was shown to be effective.  Al-hihi et al. (2017) encouraged nursing involvement with 
protocols for screening and placing fliers in visible view for patients.  Al-hihi et al. 
(2017) noted the increased rates by a best practice intervention but added that nursing 
involvement and patient engagement would further enhance success of birth-cohort 
screenings.  Instituting a BPA in the EHR proved effective in the study by Nitsche, 
Miller, Giorgio, Berry, and Muir (2018).  However, there were improved results in testing 
when the BPA was combined with ongoing feedback and education to providers about 
their clinical performance regarding HCV screenings (Nitsche et al., 2018).  Pilger and 
Costanzo (2018) stated that nurses can help overcome HCV screening challenges by 
educating patients on the importance of screening.  Education can dispel myths and 
misconceptions that the patient may have (Pilger & Costanzo, 2018).  Introduction by 
nursing staff about the importance of screening may be all the patient needs to agree to 





not brought to their attention (Pilger & Costanzo, 2018).  Discussing HCV testing during 
lab visits could possibly increase screenings since the patient is already onsite (Pilger & 
Costanzo, 2018).  
There have been barriers to screening in primary care.  Notable barriers include; 
access to screenings, patient and provider awareness of screenings, attitudes toward 
screenings, patient office visit time, and the overwhelming patient load in primary care 
(Jemal & Fedewa, 2017; Jewett et al., 2015; Konerman et al., 2017; Kruger et al., 2017; 
Southern et al., 2014).  Konerman et al. (2017) noted that even though a BPA increased 
HCV screenings 5-fold by decreasing the burden of primary care providers to remember 
to screen, there has been “alert fatigue” reported in the past.  In primary care, providers 
may have automatic prompts that present upon entering a patient’s chart.  These prompts 
may alert the provider of best practices or screenings that should be completed.    
Providers can potentially become overwhelmed with these alerts due to limited office 
visit time and the multiple medical conditions that patients can present with (Konerman 
et al., 2017).  The BPA in the Konerman et al. (2017) study was designed to reduce the 
possibility of “alert fatigue” by incorporating feedback from the primary care provider 
that would enable testing to be more feasible in practice (Konerman et al., 2017).  Nitsche 
et al. (2018) noted that EHR reminders can add to provider burden in primary care.  
Southern et al. (2014) noted that multistep tasks to determine patient screening status 
were unlikely to be performed by physicians; therefore, if this task was placed outside of 
the patient-physician visit it was more likely to be completed.  Screening rates declined in 
the Southern et al. (2014) study, despite continuous reminders suggesting that adherence 





with screening practices.  Those who are tested require adequate follow up in the event 
the initial screening test is positive, however, many of those who test positive are lost to 
follow up care (Konerman et al., 2017).   
Despite some gaps, there was sufficient evidence in the literature to guide a 
quality improvement project.  There was strong evidence of a need for screening and  
indications that screening should occur in the primary care setting.  Best practice alerts 
and nursing education were identified as potentially helpful, and barriers to success have 
been identified.  
Theoretical Model 
The primary care setting provides continuity of care to all patient populations.  
The Institute for Healthcare Improvement (IHI) Triple Aim and The Health Belief Model 
(HBM) are theoretical frameworks that combine an integrative approach to care and 
guides teaching of patient populations (IHI, 2018; Rural Health Information Hub [RHIH], 
2018).  The Triple Aim is an integrative approach to improve care, the health of  
our populations, and reduce per capita cost (IHI, 2018).  The HBM was used to guide the 
thought process and approach to learning for the patient (RHIH, 2018).  
The HBM is based on factors that predict health behavior participation.  An 
individual’s perceived perceptions, modifying factors, and the likelihood that one will 
perform the action are the premises of this model (Syx, 2008).  The HBM is comprised of  
six concepts, including; perceived susceptibility, perceived severity, perceived benefits, 
perceived barriers, cues to action, and self-efficacy (Curran, 2014).   
The HBM guided project planning for patient education.  It is a framework that 





participate in a positive health action (Behavioral and Social Sciences Research, n.d.).  
Birth-cohort testing involves a one-time HCV screening of the baby boomer population.  
Hepatitis C is a negative health consequence.  The desire to know if Hepatitis C infection 
is present, served as a motivator for the baby boomer population to participate in 
screenings.  Perceived susceptibility was introduced to the patient by making them aware  
of their risk.  Perceived severity, regarding risk and consequences was explained to 
ensure understanding of how Hepatitis C could be affecting them.  Perceived benefits of 
screening and treatment was explained to ensure their understanding of how Hepatitis C  
is identified and managed.  Perceived barriers of screening was addressed by clinical 
staff, based on the patients’ behaviors, comments, and questions.  The cues to action were 
based on patients’ decision to be screened.  If the patient agreed, they were screened.  If 
they did not agree, they were provided information based on their learning need.    
Clinical staff have a genuine concern for patient well-being.  The rising number of 
Hepatitis C virus infections combined with the notable risk to this patient population 
were the foundation for professional readiness and motivation.     
Project Purpose/Specific Aim 
The purpose of this project was to increase HCV screenings in the 1945 to 1965 
birth-cohort in an outpatient family practice, a primary care setting, in Virginia by 
providing HCV education and alerts to clinical staff, and thus increasing awareness of  
Hepatitis C and screening recommendations of this birth-cohort.  Specifically, the aim of 
this project was to increase Hepatitis C virus screenings in the 1945 to 1965 birth-cohort  







 The entire clinic population of patients born between 1945 and 1965 that came in 
for appointments during the study time frame were screened for potential participation. A 
total of 899 patients from this birth-cohort were seen for either lab or provider 
appointments during the study period.  Of the 899 patients evaluated, a total of 353 were 
found to be previously screened resulting in 545 patients who yet required screening. 
Project Setting & Study Methods 
Setting 
 This project took place at an outpatient family practice clinic, a primary care 
setting, in Southwest Virginia.  The outpatient family practice clinic is a non-profit 
satellite clinic with 5,000 active patients.  The clinic employs four providers and six  
clinical nursing staff, including; two Doctor of Osteopathic Medicine providers, one 
Doctor of Medicine, one Family Nurse Practitioner, two Registered Nurses, three 
Licensed Practical Nurses, and one Certified Medical Assistant, who also serves as the 
Laboratory Technician.  The practice is considered a medical home clinic that provides 
medical care to children, starting at birth to the geriatric population.  For purposes of this 
project, the focus was on those individuals born between 1945 and 1965.    
Intervention 
The intervention utilized the Plan, Do, Study, Act (PDSA) cycle in two phases, 
guided by the aforementioned theoretical frameworks and models (IHI, 2018).  Project 
study period started on May 28, 2019 and ended on August 12, 2019, for a total of 12 
weeks.  Plan – The “plan” phase of the PDSA cycle began when a provider recognized 





literature review was completed, which served as the basis for a quality improvement 
project proposal.  Approval for the project was granted by the Institutional Review Board 
at the participating institution and James Madison University Investigational Review 
Board.  Local HCV information also guided the planning phase.  During the planning 
phase it was identified that there were no protocols or consistency among providers 
within the outpatient practice setting to screen the 1945 and 1965 patient population for 
this problem.  Also identified was that Hepatitis C Virus screening recommendations 
were not mandatory practice.  Clinical nursing staff, providers, and patients were 
stakeholders in this project.  Also, during the planning phase, baselines were established.  
The institution’s clinical research and development team assisted in data collection and 
development of the data collection tool for statistical analysis. Prior to implementation of 
the PDSA cycle, a retrospective chart audit was conducted by the facility’s research and 
analytics team to determine the number of active baby boomers in the clinic from June 1, 
2015 to December 31, 2018 that needed to be screened.  New patients who joined the 
practice after December 31, 2018, who had not been screened were included in the study 
as well.  Those previously screened for HCV, had a diagnosis of HCV, or previous lab 
test for HCV were identified but excluded from HCV education.  Finally, educational 
materials were evidence based from the CDC and VDH.  Materials included; Fliers from 
the CDC regarding HCV in the baby boomer population, general HCV information from 
the CDC, graphs showing the prevalence of HCV in the local region and state of 
Virginia, and an HCV information sheet from the Virginia Department of Health in 
Appendix A, B, C, D, E.  A pre/post-test was created based on the educational materials 





Do - The “do” phase of the PDSA cycle started with an HCV educational 
intervention conducted for clinical staff and a one week “test” of the project.  The HCV 
education in-service was conducted for clinical staff on May 23, 2019.  HCV education   
included; HCV prevalence, screening recommendations, local/regional statistics, project 
materials, and initiation of project implementation.  Education materials were obtained  
from the Centers for Disease Control and Prevention and the Virginia Department of 
Health (Appendix A, B, C, D, E).  A pre and post-test based on the information provided, 
was given to clinical nursing staff to evaluate their knowledge of HCV before and after 
the in-service.  Project guidelines were disseminated to staff and displayed in the nurse’s 
station throughout the project process.  Information fliers obtained from the CDC website 
for the screening of HCV in those born between 1945 and 1965 were displayed in each 
patient room, lab, waiting and triage areas, for patients to observe (Appendix A).  
Information provided to clinical staff was based from the CDC and the VDH (Appendix 
A, B, C, D, E).  Information from the CDC included; general Hepatitis C “know more 
hepatitis” information from the CDC website (2018), Hepatitis C General Information 
Fact Sheet (2015), and Hepatitis C: Why Baby Boomers Should Get Tested  
Fact Sheet (2016).  Information from the VDH, included; Hepatitis C Fact Sheet (2018) 
and Chronic Hepatitis C data (2017), which showed the prevalence of Hepatitis C in the 
locality and state of Virginia.  HCV information was disseminated from clinical staff to 
the baby boomer population, who were not previously screened.  Data was extracted from 
the EPIC electronic health record system.  The provider and lab schedules were reviewed 
daily to identify patients born between 1945 and 1965 by year of birth.  A list of patients 





provider or the laboratory technician.  The primary nurse or laboratory technician 
provided HCV education to the patient and asked them to be screened.  If the patient 
agreed, a lab order for the Hepatitis C antibody was placed.   
The “test” of the project included the principle investigator and Registered Nurse.  
The “test” of the project began on May 28, 2019 and continued through May 31, 2019.  
The purpose of this cycle was to test the flow and process of the project before it was 
expanded out to involve all four providers in the office.  Patients born between 1945 and 
1965 were identified on the principle investigator’s schedule.  A review of Epic 
determined the patient’s HCV screening status.  Patients who did not have a recorded  
HCV screening test in their chart history were provided HCV education by the nurse, 
advised of their HCV risk, and asked if they wanted to be screened.  If the patient agreed 
to be screened, a lab order for the Hepatitis C antibody was placed.   
Study - The “study” phase of the PDSA cycle, was an analysis of the “do” phase.    
During the study phase, the test phase of the project was reviewed to determine if there 
were any issues, process, or flow changes that needed to be changed or implemented 
prior to advancing to the next phase.  It was determined that there were no issues or 
changes that needed to be implemented prior to the next phase.   
Act - The “act” phase (Phase 2) of the PDSA cycle was expanded to include the 
three physicians in the office and the lab.  This phase was initiated on June 3, 2019 and 
continued through August 16, 2019 for a total of 12 weeks.   
Clinical staff were given verbal reminders about the project daily.  An identified 
list of patients who were to present for the day were enlisted with the primary nurse of 





the nurse’s station, lab, waiting rooms, and patient care areas.  These measures were also 
to ensure ongoing awareness of the project and the need for HCV screening in the baby 
boomer population.  Weekly meetings were held with the office clinical team leader and 
office manager to review the project process.  
Financial Cost 
 On June 2, 2014, The Department of Health and Human Services, Centers for 
Medicare and Medicaid Services (CMS) approved a one-time screening test for adults 
born between 1945 and 1965 who are enrolled under Medicare Part A and B (CMS,  
2015).  Coverage for Hepatitis C testing must be ordered in the primary care setting by a 
primary care provider who is a Medicare provider and coded with the diagnosis code 
Z11.59 (CMS, 2015).  Financial costs were considered prior to project implementation. 
Financial coverage for HCV screenings were verified with insurance payors prior to 
project implementation.  Patients who were self-pay were advised of the costs they would  
incur if they chose to be screened.  No extra staff or extended resources were needed.  No 
overtime expenses were required or incurred by staff.  There was no additional visit cost 
for the patient.  Patients were informed of the costs prior to testing.  The testing and 
processing fee charged by the participating laboratory for the Hepatitis C antibody lab 
test in the office was $56.00.  The lab collection fee was $16.00 charged by the 
institution.  The institution allowed a 10% discount for self-pay patients, who were 
paying on the same day, resulting in $14.40 for self-pay patients.  The cost incurred was 








 Analysis of the project data was conducted following completion of the study.  
Information that was uploaded into the REDCap system to categorize data was extracted 
for statistical analysis (REDCap, 2019).    
Participant Description 
Total number of patients seen during the time frame was counted. Number of 
active patients were counted.  Number of patients seen by day and week were averaged.  
Frequencies of geographical zip codes were identified for patients seen were calculated. 
Frequencies were computed to determine the race of those screened.  Central tendency 
measures were used to calculate the ages of those who were screened and were separated 
by positive and negative testing results.  Frequencies were used to describe the type of 
insurance carried by those who were screened.  
Pre/Post Project Screening Rates and Results 
 The total percent of patients screened at study end was compared to the total 
number of patients screened ever prior to the study.   
 ANOVA Procedure and Duncan’s post hoc was used to evaluate and compare the 
number of screening tests obtained during each month of the study to determine if there 
were significant differences among and between the months of testing. 
 Fisher’s Exact Test was used to determine the statistical significance in screening 
status among patients seen for a lab visit versus those seen for a provider visit. 
Reasons not Screened 
 Frequencies were used to calculate the number and percent for reasons people 





HCV Screening Rates: Lab verses provider visit 
 Frequencies were used to calculate the number of patients who agreed to be 
screened, and those not screened, when seen at a lab visit and when seen for a provider 
visit. A Chi-Square with Fisher’s Exact Test was used to determine if there were 
significant differences in those who agreed to be screened depending on the type of visit 
(lab as compared to provider).  
Clinical Staff Education 
The educational intervention included a 10-question pre and post-test that was 
given to all six clinical nursing staff.  The pre and post-test was given to evaluate the 
clinical nursing staff’s knowledge of HCV before and after the in-service.  Frequency 
testing was used to evaluate pre and post-test results.  
Findings 
The entire clinic population of patients born between 1945 and 1965 that came in 
for appointments during the study time frame was screened for potential participation. A 
total of 899 persons from this birth-cohort were seen for either lab appointments or 
provider appointments during the study time period. Of the 899 patients seen, a total of 
353 were found to be previously screened resulting in 545 patients who yet required 
screening. Of the 545 total eligible patients for screening, 254 were not screened for 
various reason, 288 were screened (n=284), or were scheduled to be screened (n=4) by 
study end. There were three participants seen during the “test” phase, that were not 
included in the significance testing.    
Of the 284 persons who agreed to be screened and completed screening prior to 





Medicare = 132 (46%), Medicaid = 5 (2%), and Veteran’s Affairs = 1 (<1%), for a total 
of 138 persons with government insurance (49%). Commercial insurance carriers were 
the second largest primary payor for patients who agreed to be screened, with a total of 
136 patients (48%). Six patients (2%) were self-pay. Four patients (1%) did not have 
insurance listed.  
Pre/Post Project Screening Rates and Results (Project Aim) 
 During the time frame, 899 patients were seen in the clinic who met the age range 
eligibility criteria. Of the 899 patients seen, a total of 353 had been screened prior to the 
project leaving 545 potential patients for screening. During the 12-week project period 
from May 28, 2019 to August 16, 2019, 288 patients were screened (n = 284) or 
scheduled to be screened post study (n = 4) for HCV. Although there is some potential 
that members of the 4 persons scheduled to be screened post study did not actually 
receive screening, for the purpose of these results all persons screened or scheduled for 
screening at study end are considered screened.  
 There are 2,612 total patients from within the baby boomer generation who are 
recorded as active patients in the clinic. The baseline screening rate for patients seen in 
the clinic prior to the intervention was 30.97% (n=809) (Figure 1). This number indicates 
the total number of patients seen in this clinic and screened at any location in the health 
system, and thus may indicate a higher baseline screening rate than the actual clinic rate 
only. A 30% increase from the baseline screening rate puts the goal of screened patients 
at 40.26% (Figure 1).  
At study end the total rate of eligible patients screened was 42.19% (n=1102). 





the clinic. Of the 545 patients eligible to be screened during the study period, patients 
who had a visit and no prior screening 288 (52.84%), were screened or scheduled to be 
screened by study end. Of the 899 patients seen during the study, 353 were previously 
screened and 288 were screened or scheduled to be screened by study end. The number of 
new screens (n=288) divided by the number of patients seen who were previously 
screened (n= 353) demonstrates an 81.59% increase in screenings rates among those seen 
during the study period. 
Four tests results were not returned by study end; thus 284 test results are known 
for during the study period. Of the 284 persons with returned tests results, there were a 
total of 134(47%) who identified as females and 149(52%) who identified as males were 
screened and one data point was missing. Of the 284 returned tests, 6(2%) resulted in 
abnormal testing and 277(98%) resulted in normal test results and one missing data point 
is missing. Of the six tests that were abnormal, one patient (17%) identified as African 
American and five patients (83%) identified as Caucasian. Of the 6 abnormal tests, the 
mean age was 62 (Range 55 – 74). The normal test results showed similar age mean, 64, 
and range (52-74). 
There was a significant difference (p = 0.008) in the daily screening rates by 
month. Duncan’s post hoc analysis showed that screening rates were significantly higher 
during days in June (6.55/day) as compared to days in July (4.77/day) and August 
(3.75/day). There was not a significance in testing rates between July and August, 







Reasons not screened 
 The majority of patients who declined testing did not give a reason. There were 
clear reasons for not being tested for 126 patients. The most common reason for not being 
tested was that the patient was acutely ill and thus too ill to discuss (n=61). Some patients 
(n=26) reported being tested in the past even if there was no record of them being tested 
in the health record. Other patients (n=16) declined because of not wishing to have HCV 
labs only drawn. Six patients declined because they would need to pay for the test out of 
pocket. Some patients (n=17) were not tested because of nurse oversight.  
HCV Screening rates: Lab versus provider visits  
For the 284 patients with test results by study end plus the 254 seen during the 
study and not screened, and recalling that 3 patients were not included, there was a 
statistically significant (p<0.001) higher number of patients who agreed to be screened 
during lab visits as compared to during provider visits.  Among the patients who were 
scheduled for a clinic lab visit 84(62%) agreed to be screened and 18 (13%) were not 
screened (Figure 3).  Of the patients scheduled for a provider visit, 200(26%) agreed to 
be screened and 236(31%) were not screened (Figure 3).  
Clinical Staff Education 
 Evaluation of the pre and post-tests showed a trend in improvement of HCV 
knowledge.  Six clinical nursing staff (n=6) participated in a 10-question pre and post-test 
based on their HCV knowledge before and after the in-service.  The mean number of pre-
test correct answers was 9.  The mean number of post-test correct answers was 10.  
Overall, clinical nursing staff were found to have strong knowledge of HCV both prior to 





of nursing disciplines, comparison testing between education levels and HCV awareness 
could not be further investigated.  
Discussion 
Development and implementation of this project was due to the increasing 
prevalence of HCV in our locality (VDH, 2017).  According to the CDC (2018) baby 
boomers are at high risk for long term effects related to HCV while many are unaware of 
their risk.  Based on the literature, the study utilized clinical nursing staff to educate the 
birth-cohort at each office visit (Pilger & Costanzo, 2018; Al-hihi et al., 2017; & 
Madhani et al, 2017).  HCV fliers obtained from the CDC were placed in patient care 
areas as suggested by Madhani et. al. (2017).  This strategy proved to be effective in 
acknowledging the HCV issue.  Staff noted numerous inquiries from patients wanting to 
know more information about HCV after reading the fliers in the patient care areas.  This 
alone helped to facilitate the discussion.   
This study was based largely on the recommendation by Pilger & Costanzo 
(2018) to utilize nursing staff to promote HCV screenings by educating patients.  It was 
suggested that the combination of education and support by nursing staff can help to  
dispel myths and misperceptions of HCV and testing (Pilger & Costanzo, 2018).  Patients 
in the practice seem to value the nursing staff.  Many were long time patients in the clinic 
and had a rapport with the clinical staff entrusted with their care.  Nurse-patient 
engagement at triage was an opportune time for nursing staff to discuss HCV.  The 
assumption proposed by Pilger & Costanzo (2018) that patients may readily agree to be 





readily agreed to HCV screening when they were told of their HCV risk just by being 
born in the baby boomer cohort.   
HCV screenings increased during the study period (Figure 1).  Clinical nursing 
staff’s knowledge of HCV was found to be strong based on pre and post-test results.  Pre 
and post-test results showed a minimal trend in improvement, but minimal.  It is 
inconclusive to say that clinical staff education improved HCV screenings.  It can be 
debated that increasing the awareness of HCV of staff increased screenings.  Pilger & 
Costanzo (2018) stated that the discussion of HCV screening recommendations may be 
the only mechanism needed to increase screenings.    
HCV screenings during the lab visit proved to be effective.  Pilger & Costanzo 
(2018) suggested that HCV screenings may increase if discussed during lab visits.  Lab 
visits are not held to the same time restraints as provider visits, therefore, clinical nursing 
staff can discuss health topics.  Incorporating HCV screening discussions were top 
priority during the study period, making this an opportune time for HCV patient 
education.  The data showed that patients were more likely to have screening tests 
obtained when they presented for their lab visit (Figure 3).  This coincided with the fact 
that patients declined screening because they had already had lab work obtained.  Patients 
were willing to return to have this done with their regular lab work.  Patients were 
receptive to being screened when they learned that testing was by blood work, which they 
were already there to have drawn.  This was evident by patients’ refusal of testing at the 
time of provider visit due to not having labs drawn.  Providers placed an HCV screening 





Screening rates were higher at the start of the study, versus the end of the 12-week 
study period (Figure 2).  July and August screening rates were statistically the same.  
Southern et al. (2014) reported decline in testing adherence during their study period 
citing the decline was mostly due to clinical staff attitudinal barriers.  It is speculated that 
staff were more motivated at the start of the study versus the end of the study as 
evidenced by nurse oversight as a reason for not being screened.  The PDSA cycle served 
as a step-by-step guide and evaluation in the project process.  It was important to 
maintain continuous feedback with staff members involved in the project at each cycle of 
the study.  Staff were given verbal reminders and lists of patients to be screened each day 
by the project investigator.   
It has been noted by previous literature that an EHR reminder substantially 
increased screenings.  EHR alerts proved to be effective in the Al-hihi et al. (2017); 
Litwin et al. (2011); Konerman et al. (2017); and Nitsche et al. (2018) articles.  There has 
also been literature that noted EHR was not enough.  Notable articles that used education  
with or without EHR included; Litwin et al. (2011); Madhani et al. (2017); Nitsche et al. 
(2018); Pilger & Costanzo (2018).  Combining staff education with EHR alerts can be  
more effective to increase screenings, however, “alert fatigue,” was mentioned as a 
possible barrier to HCV screenings in Konerman et al. (2017).  Alert fatigue can be 
experienced among care providers, who are already overwhelmed with alerts and 
management of numerous chronic conditions, in an already time-limited patient visit.  
These alerts can be overridden and ignored.  For this reason, it was chosen not to 





Financial costs for a one-time screening test is no comparison to the financial 
burden that can be incurred by undiagnosed HCV.  Galbraith et al. (2014) analyzed 
national databases for evaluation of national healthcare utilization by those with a 
diagnosis of HCV or liver-related complication (Galbraith et al., 2014).  Baby boomers 
infected with HCV accounted for 72.5% of outpatient ambulatory visits, 67.6% of 
emergency department visits, and 70.7% of inpatient admissions (Galbraith et al., 2014, 
p. 755).  Xu, Tong, & Leidner (2014) evaluated hospitalizations and costs in relation to 
liver disease.  The largest cohort utilizing inpatient healthcare services from 2004 to 2011 
were those born between 1945 and 1965 (Xu et al., 2014, p. 1733).  The percent of baby 
boomers hospitalized due to liver related issues increased from 68.7% in 2004-05 to 
77.3% in 2010-11 (Xu et al., 2014, p. 1732).  Inpatient costs due to HCV in 2010-11, was 
estimated to be at $3.5 billion (Xu et al., 2014, p. 1732).  More recently, this number is 
estimated to be at $15 billion annually (Xu et al., 2014, p. 1732).  This is thought to be 
due to the increased aging and the developing onset of severe liver disease.   
The Department of Health and Human Services, Centers for Medicare and 
Medicaid approved a one-time screening test for baby boomers enrolled under Medicare  
Part A and B, if it is ordered by a primary care provider participating with Medicare in a 
primary care office (CMS, 2015).  An almost equal percentage of government and 
commercial insurances were noted to be the primary payors for the patient population in 
the study.  Government insurance (Medicare, Medicaid, and Veterans Affairs) were the 
predominant payors in the study 49%.  Commercial insurance payors were at 48%   
Participating insurance payors covered the cost of testing.  Self-pay patients comprised 





The study found six patients to be positive for HCV, who did not know they had 
it.  They would not have known unless they had been screened.  Of the patients screened, 
the majority were Caucasian males, average age of 62.  Statistically there was no 
difference between gender in percentage screened.  Average age of all patients screened 
was 64.  Five of six abnormal results were males.  Average age of all patients with 
positive screens were 62.    
The study followed the CDC (2018) and The USPSTF (2016) recommendations 
to identify and screen the baby boomer population in primary care to find undiagnosed 
HCV due to continuum of care provided by primary care providers.  The six patients who 
were identified and found to be positive, can now be referred for treatment.  This one-
time screening test prompted by this study may have ultimately saved their lives.  
 Even though, no BPA was not used in the study, the project proved to be 
successful.  HCV screenings of the baby boomer population increased by 82% in a 12-
week time frame.  By project end, the total number of baby boomers screened for the 
practice increased from 31% to 42%   
Barriers 
 The type of visit, patient perception, testing location, and staffing issues were 
barriers encountered during the study period.  Some of the barriers encountered during 
the study were echoed in previous articles researched for this study that included; access 
to screenings, patient and provider awareness of screenings, attitudes toward screenings, 
patient office visit time, and the overwhelming patient load in primary care (Jemal & 
Fedewa, 2017; Jewett et al., 2015; Konerman et al., 2017; Kruger et al., 2017; Southern et 





Providers and clinical staff were very receptive to implementing the project.  
Providers and clinical nursing staff in the practice care about the health and well-being of 
their patient populations.  They were willing to take the necessary steps to take care of 
their patients.  The project was developed on the idea that nursing staff would provide 
HCV education to the patient. Unfortunately, it is unclear if this took place at each patient 
encounter.   
Given the number of nurse oversights, nursing staff may have been somewhat of a 
barrier to testing.  Nursing staff seemed to have a “project fatigue,” toward the end of 12-
week period.  There were oversights of patients noted, even though there were fliers and 
daily reminders of the project.  Patient screenings missed by nurses, could have been 
caught by providers so it can be surmised that providers relied on nursing staff to ensure 
screening was completed and did not pursue this any further.   
Some nursing staff did not actually order the HCV screening test.  They either 
told the provider or pended the test, instead of submitting the order.  Al-hihi et al. (2017) 
noted the addition of written protocols would allow nursing staff to place orders for HCV 
screenings.  A written protocol was not developed for clinical nursing staff for this 
project.  It was verbally stated to them they could place the order.  It was later learned 
that some staff members were hesitant to place the order even if it was verbally 
understood they could.  Providers may have assumed that nursing staff provided HCV 
education and HCV testing was ordered, or patient refused if not communicated 
otherwise.  Providers may have overlooked HCV discussions as well if there were other 





be speculated.  HCV discussions were found not to be appropriate during certain patient 
encounters due to the nature of the visit.     
Visit time did not necessarily seem to be a factor in the study based on 
nurse/provider feedback.  HCV patient education started at triage.  Nursing staff reported 
minimal questions asked by patients.  Patients often agreed when nursing staff introduced 
the topic of HCV and asked them to be screened.  Patients readily agreed when they were 
told screening was by lab draw.     
Patient perception was a barrier to testing.  The majority of patients who were not 
screened, declined without providing a reason.  Some patients reported that if they had 
HCV, they did not want to know.  The type of visit the patient presented for was a barrier 
to testing.  If patients were acutely ill or encounters presented in which it was not 
appropriate to discuss HCV, screenings did not occur.  Some patients stated they had 
been tested in the past, however, this could not be verified.  
Timing of the study proved to be a factor due to regular staff being on vacation 
and float staff being present.  Float nurses were not familiar with the process and may 
have not provided education to those who needed to be tested.  Patient list of those who 
needed to be screened were overlooked if the primary nurse or the provider was not 
present, or a different clinician was in the lab.  Steps were taken to ensure all staff  
members presenting for the day were notified of the process.  It is unclear if adherence 
was followed at its entirety.   
Other factors presented as barriers in the study.  Provider call-ins resulted in 





insurance was a small barrier to screening.  Self-pay patients or those with restrictive 
insurances did not want testing that they felt was “unnecessary.”  Even though education 
was provided about HCV there were still some patient perceptions that did not change.     
Limitations 
This project was implemented in one small outpatient practice setting with only 
six clinical nursing staff and four providers.  This project may be more difficult if carried  
out in a larger setting with more staff members, unless there are other measures put into 
place to avoid any missed screenings.  Project time was limited to 12-weeks.  It is 
difficult to know what further outcomes would be possible without extending the project 
time.  Timing of the project may be important as well.  Unfortunately, the project took  
place in the summer months while staff members who would have normally been present, 
were on vacation.  There were many float nurses that patients were not use to.  Float 
nurses were unaware of the process and the patients, which may have impeded 
screenings.  The practice has a large Caucasian population, baby boomer, and geriatric 
population which may have skewed the race and age findings.   
Conclusion 
This project was necessary to evaluate how the practice was screening this patient 
population. HCV education was needed to promote awareness of how prevalent and 
debilitating this virus can be, but education is not enough.  This project shows that not 
only nursing staff need to be vested in screening these individuals, but everyone directly 
involved in patient care also has responsibility to discuss and screen.  HCV may not 
present with symptoms for decades putting the baby boomer population at risk indicating 





population and preclude the risk of mortality.  The project showed how HCV awareness 
can increase screenings in the baby boomer population in outpatient family practice.    
Recommendations/Implications for Practice 
 This quality improvement project built upon current literature that suggested 
involving nursing staff to educate patients about HCV could improve screenings in 
outpatient primary care.  Utilizing clinical nursing staff to educate patients at each 
encounter, even when the patient presented for labs only was found to be effective in 
increasing HCV screenings.  EHR has been shown to increase screenings but should not 
be relied on completely for screenings alone.  EHR alerts have the potential to be 
overridden, resulting in missed opportunities to screen for HCV.  It is important to sustain 
testing with ongoing education.  The education and ongoing awareness of HCV 
screenings in the baby boomer population in this outpatient family practice facility, was 
the motivator for practice change that continues to this day.  Nursing staff and providers 
continue to identify, educate, and screen those born between 1945 and 1965.  There were 
inferences that presented upon review of the data. More patients were identified and 
agreed to screenings when they presented for their lab visit.  Future studies can build 
upon this study or develop educational opportunities by nursing staff to identify, educate, 
and screen during a lab visit or when labs are being drawn. Educational fliers helped to 
facilitate dialogue for testing.  The use of fliers may help promote awareness for future 
quality improvement projects.  Future studies can investigate barriers to screening test 









HCV Information Fact Sheet obtained from the CDC website used for clinical staff 
education and patient awareness.  Information fact sheet was displayed in patient care 
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Graph of HCV prevalence in the locality where study took place.  Presented to clinical 












Graph of HCV prevalence in the state of Virginia.  Presented to clinical nursing staff for 











HCV Fact Sheet obtained from the VDH website.  Fact sheet was used for clinical staff 
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